Amalgamated Bank’s Organogenesis Holdings ORGO Stock Holding History
Bought
Maintained
Sold
Other funds holding ORGO
SCM
FLAM
VCM
Amalgamated Bank's ORGO Position: Q1 2026 in Review
Amalgamated Bank sold out of Organogenesis Holdings (ORGO) in Q1 2026, closing a stake of 2,146 shares — an estimated $11K sold.
Amalgamated Bank first reported a position in ORGO in Q2 2021 and held it in 19 quarters. The position peaked at $408K in Q3 2021. 121 funds tracked by Wall St. Rank hold ORGO as of Q1 2026.
- Amalgamated Bank reported no remaining Organogenesis Holdings position as of Q1 2026 after selling out during the quarter.
- Amalgamated Bank sold 2,146 Organogenesis Holdings shares in Q1 2026, an estimated $11K.
- Amalgamated Bank first reported a position in Organogenesis Holdings in Q2 2021 and held it in 19 quarters.
- Amalgamated Bank's Organogenesis Holdings position peaked at $408K in Q3 2021.
- 121 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q1 2026.
Based on Amalgamated Bank's 13F filing for Q1 2026, filed 8 May 2026.